Señales en vivo de FOXW | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 ene 2023 @ 15:06):

Stats
Volumen de hoy	730.00
Volumen promedio	5 741.00
Capitalización de mercado	0.00
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0480 (0.47%)

Insider Trading

Date	Person	Action	Amount	type
2021-01-19	Foxwayne Enterprises Acquisition Sponsor Llc	Buy	100 000	Class B common stock, par value $0.0001 per share

INSIDER POWER
0.00
Last 0 transactions
Buy: 0 \| Sell: 0

Volumen Correlación

Largo: -0.14 (neutral)

Corto: -0.63 (weak negative)

Signal:(48.923) Neutral

FoxWayne Enterprises Correlación

10 Correlaciones Más Positivas
GETVV	0.845

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

FoxWayne Enterprises Correlación - Moneda/Commodity

0.42
( neutral )

0.53
( weak )

0.00
( neutral )

0.38
( neutral )

-0.67
( moderate negative )

-0.26
( neutral )

FoxWayne Enterprises Finanzas

Annual	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.145

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.145

FY	2020
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.00100

Financial Reports:

No articles found.

FoxWayne Enterprises

FoxWayne Enterprises Acquisition Corp. does not have significant business. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biotechnology and/or telemedicine sector of the healthcare industry in North America. The company was incorporated in 2020 and is based in New York, New York.